Cameco Corp: Form 40-F for the period ended Dec 31, 2023
Filed with the SEC on Mar 22, 2024 and accepted by EDGAR at Mar 22, 2024, 17:22 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | CAD 2.59bn | ifrs-full:Revenue |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | CAD 2.03bn | ifrs-full:CostOfSales |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | CAD 561.7m | ifrs-full:GrossProfit |
| Operating income | 12 months2023-01-01 to 2023-12-31 | CAD 282.9m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2023-01-01 to 2023-12-31 | CAD 126.3m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2023-01-01 to 2023-12-31 | CAD 360.8m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | CAD 0.83 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | CAD 0.83 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | CAD 688.1m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | CAD 153.6m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2023-12-31 | CAD 566.8m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2023-12-31 | CAD 1.84bn | ifrs-full:CurrentAssets |
| Total assets | At period end2023-12-31 | CAD 9.93bn | ifrs-full:Assets |
| Current liabilities | At period end2023-12-31 | CAD 1.19bn | ifrs-full:CurrentLiabilities |
| Shareholders' equity | At period end2023-12-31 | CAD 6.09bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | At period end2023-12-31 | 434,175,752 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-24-075464. Last ingested by Listed: Nov 6, 2026, 13:21 ET. Listed shows no prices and gives no investment advice.